Stock of the Day: Could Henry Schein, Inc. See a Reversal After This Very Weak Session?

Stock of the Day: Could Henry Schein, Inc. See a Reversal After This Very Weak Session?

The stock of Henry Schein, Inc. (NASDAQ:HSIC) is a huge mover today! About 1.17 million shares traded hands or 132.57% up from the average. Henry Schein, Inc. (NASDAQ:HSIC) has declined 8.07% since March 11, 2016 and is downtrending. It has underperformed by 13.53% the S&P500.
The move comes after 8 months negative chart setup for the $12.42 billion company. It was reported on Oct, 14 by We have $144.96 PT which if reached, will make NASDAQ:HSIC worth $745.20M less.

Analysts await Henry Schein, Inc. (NASDAQ:HSIC) to report earnings on November, 2. They expect $1.65 EPS, up 6.45% or $0.10 from last year’s $1.55 per share. HSIC’s profit will be $132.89M for 23.37 P/E if the $1.65 EPS becomes a reality. After $1.64 actual EPS reported by Henry Schein, Inc. for the previous quarter, Wall Street now forecasts 0.61% EPS growth.

Henry Schein, Inc. (NASDAQ:HSIC) Ratings Coverage

Out of 9 analysts covering Henry Schein Inc. (NASDAQ:HSIC), 4 rate it a “Buy”, 0 “Sell”, while 5 “Hold”. This means 44% are positive. Henry Schein Inc. has been the topic of 10 analyst reports since July 31, 2015 according to StockzIntelligence Inc. The stock has “Hold” rating given by Evercore on Friday, July 31. The stock of Henry Schein, Inc. (NASDAQ:HSIC) has “Buy” rating given on Monday, September 12 by Bank of America. The firm has “Buy” rating given on Tuesday, October 11 by Goldman Sachs. The firm earned “Buy” rating on Thursday, October 6 by UBS. The firm has “Outperform” rating by RBC Capital Markets given on Thursday, November 5. Piper Jaffray maintained Henry Schein, Inc. (NASDAQ:HSIC) rating on Thursday, February 11. Piper Jaffray has “Neutral” rating and $159 price target. The stock of Henry Schein, Inc. (NASDAQ:HSIC) has “Hold” rating given on Friday, November 6 by Gabelli. The firm has “Neutral” rating given on Friday, October 14 by Robert W. Baird.

According to Zacks Investment Research, “Henry Schein, Inc. is the largest distributor of healthcare products and services to office-based healthcare practitioners in the combined North American and European markets. The company conducts its business principally through two segments; healthcare distribution and technology. These segments, which are operated as individual business units, offer different products and services, albeit to the same customer base. The healthcare distribution segment consists of the company’s dental, medical, veterinary and international groups.”

Insitutional Activity: The institutional sentiment decreased to 0.92 in 2016 Q2. Its down 0.10, from 1.02 in 2016Q1. The ratio is negative, as 25 funds sold all Henry Schein, Inc. shares owned while 187 reduced positions. 44 funds bought stakes while 150 increased positions. They now own 74.55 million shares or 10.43% less from 83.23 million shares in 2016Q1.
Sequoia Finance Advsrs Lc owns 2,037 shares or 0.1% of their US portfolio. Blackrock accumulated 758,611 shares or 0.07% of the stock. The New York-based Bamco Ny has invested 0.36% in Henry Schein, Inc. (NASDAQ:HSIC). Cornerstone holds 18 shares or 0% of its portfolio. Natixis Asset Mgmt, a France-based fund reported 5,599 shares. Bridgeway owns 41,700 shares or 0.11% of their US portfolio. Wagner Bowman Management Corporation, a Maryland-based fund reported 1,310 shares. Alliancebernstein Limited Partnership owns 144,501 shares or 0.02% of their US portfolio. Winslow Evans And Crocker has 26 shares for 0% of their US portfolio. Norinchukin Comml Bank The last reported 4,303 shares in the company. Acadian Asset Lc, a Massachusetts-based fund reported 620,769 shares. Group, a New York-based fund reported 33,091 shares. Cadence Commercial Bank Na holds 1,134 shares or 0.1% of its portfolio. Snyder Capital Mgmt L P last reported 0.47% of its portfolio in the stock. Adage Capital Prtn Group Ltd Liability Company has 0.06% invested in the company for 122,700 shares.

Insider Transactions: Since May 12, 2016, the stock had 0 insider buys, and 5 sales for $4.84 million net activity. On Thursday, June 2 the insider BENJAMIN GERALD A sold $1.75M. Harding James A. had sold 10,302 shares worth $1.78 million. On Monday, August 29 the insider Brons Paul sold $554,585. $198,887 worth of shares were sold by McCarthy Peter M. on Thursday, May 12.

More notable recent Henry Schein, Inc. (NASDAQ:HSIC) news were published by: which released: “Henry Schein Bestows Fourth Annual International Veterinary Community Service …” on October 13, 2016, also with their article: “Henry Schein Well Poised on Strategic Buyouts, Pricing Hurts” published on October 07, 2016, published: “Henry Schein Reports Second Quarter Financial Results” on August 04, 2016. More interesting news about Henry Schein, Inc. (NASDAQ:HSIC) were released by: and their article: “Henry Schein’s Dentrix Ascend® Receives 2016 Cellerant “Best of Class …” published on August 15, 2016 as well as‘s news article titled: “Henry Schein Becomes Oversold (HSIC)” with publication date: August 04, 2016.

HSIC Company Profile

Henry Schein, Inc., incorporated on December 23, 1992, is a well-known provider of health care services and products to office dental, animal health and medical practitioners. The Firm serves approximately one million clients across the world, including dental practitioners and laboratories, animal health clinics and physician practices, as well as government, institutional health care clinics and other alternate care clinics. The Company’s divisions include healthcare distribution, and technology and value-added services. The Firm operates through a distribution network with a selection of over 110,000 products and Henry Schein private brand products in stock, as well as approximately 150,000 additional products available as special order items. The Firm also offer its customers, technology solutions, including practice management software and e-commerce solutions, as well as a range of financial services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment